Recommendations on TNFα inhibitor biosimilar use in clinical practice: a comparison of European gastroenterology IBD guidance

Rosanne W. Meijboom, Liese Barbier, Louise C. Druedahl, Kati Sarnola, Hanna M. Tolonen, Helga Gardarsdottir, Acg Egberts, Thijs J. Giezen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalExpert Opinion on Biological Therapy
Volume23
Issue number8
Pages (from-to)801-817
Number of pages17
ISSN1471-2598
DOIs
Publication statusPublished - 3 Aug 2023
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Biosimilar
  • Gastroenterology
  • Guidelines
  • Inflammatory bowel disease
  • Infliximab
  • Switching
  • Tumor necrosis factor inhibitors
  • 317 Pharmacy

Cite this